Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11296-11303

  Wang, X ^a   Zeng, W ^a   Murakawa, M ^a   Freeman, M W ^a   Seed, B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; CYCLIZATION; EPISOME; GENE CONSTRUCT; GENE EXPRESSION; GENE REARRANGEMENT; GENE SEGREGATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRUS GENOME; VIRUS RECOMBINANT;

ADENOVIRIDAE; CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION; GENE REARRANGEMENT; GENE TRANSFER, HORIZONTAL; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; PLASMIDS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC;

EID: 0034468337     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11296-11303.2000     Document Type: Article

References (51)

1. Controls of RNA splicing and termination in the major late adenovirus transcription unit
2. Evolutionary duplication of a hepatic control region in the human apolipoprotein E gene locus: Identification of a second region that confers high level and liver-specific expression of the human apolipoprotein E gene in transgenic mice
3. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted
4. Characterization of an adenovirus gene transfer vector containing an E4 deletion
5. High mutation frequency in DNA transfected into mammalian cells
6. Recombination and deletion of sequences in shuttle vector plasmids in mammalian cells
7. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
8. Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus
9. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver
10. Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors
11. Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity
12. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy
13. Manipulation of adenovirus vectors
14. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
15. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation
16. Codon usage limitation in the expression of HIV-1 envelope glycoprotein
17. Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome
18. Construction of adenovirus vectors through Cre-Lox recombination
19. The adenovirus type 5 E1A enhancer contains two functionally distinct domains: One is specific for E1A and the other modulates all early units in cis
20. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element
21. An enhancer element is located 340 base pairs upstream from the adenovirus-2 E1A capsite
22. Selective extraction of polyoma DNA from infected mouse cell cultures
23. Activation of gene expression by adenovirus and herpesvirus regulatory genes acting in trans and by a cis-acting adenovirus enhancer element
24. Common control of the heat shock gene and early adenovirus genes: Evidence for a cellular E1A-like activity
25. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy
26. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector
27. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone
28. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase
29. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants
30. Transfected DNA is mutated in monkey, mouse, and human cells
31. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector
32. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo
33. In vivo identification of sequence elements required for normal function of the adenovirus major late transcriptional control region
34. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector
35. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
36. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method
37. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
38. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors
39. c-myc products trans-activate the adenovirus E4 promoter in EC stem cells by using the same target sequence as E1A products
40. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
41. Rearrangement and mutagenesis of a shuttle vector plasmid after passage in mammalian cells
42. Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene
43. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A
44. An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency
45. Gene therapy using adenoviral vectors
46. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
47. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo
48. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
49. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
50. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
51. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit